Supernus Pharmaceuticals
SUPN
SUPN
83 hedge funds and large institutions have $298M invested in Supernus Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 26 increasing their positions, 20 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
28% more capital invested
Capital invested by funds: $234M → $298M (+$64.9M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
83
Holding in Top 10
2
Calls
$10.8M
Puts
$7.46M
Top Buyers
| 1 | +$12M | |
| 2 | +$9.56M | |
| 3 | +$2.74M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$2.2M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$1.93M |
Top Sellers
| 1 | -$8.44M | |
| 2 | -$8.34M | |
| 3 | -$3.25M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.58M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.1M |